UK 'must be cautious' of new coronavirus variants says expert When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more…
Read More
Abacavir/Lamivudine 600/300 APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ABACAVIR/LAMIVUDINE 600/300 APOTEX TABLET Contains the active ingredients abacavir (as sulfate) and lamivudine Consumer Medicine Information PATIENTS TAKING ABACAVIR AND LAMIVUDINE COMBINATION TABLETS, WHICH CONTAINS ABACAVIR, MAY…
Read More
Amlodipine/Valsartan/HCT Novartis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VALSARTAN/AMLODIPINE/HCT NOVARTIS® 5/160/12.5, 5/160/25, 10/160/12.5, 10/160/25, 10/320/25 amlodipine besilate/valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about AMLODIPINE/VALSARTAN/HCT NOVARTIS. It…
Read More
Alecensa
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ALECENSA® ROCALECE10720 alectinib hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Alecensa. It does not contain all the available…
Read More
Aprepitant APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APREPITANT APOTEX aprepitant Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available…
Read More
Naprosyn SR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NAPROSYN SR® pronounced nap-row-sin S-R contains the active ingredient naproxen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NAPROSYN SR…
Read More
Rixadone Oral
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RIXADONE Risperidone Oral solution 1mg/mL Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you start taking Rixadone. This leaflet answers some…
Read More
Orgalutran
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ORGALUTRAN® Ganirelix (as acetate) 250 micrograms in 0.5 millilitres Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Orgalutran. It does…
Read More